Cancer researchers hit a bullseye with new drug target for Ewing sarcoma

A new discovery at Boston Children’s Hospital brings new hope in the fight against Ewing’s sarcoma, as reported at ScienceDaily. Their summary:

“Researchers have found that Ewing sarcoma cells die if an enzyme called CDK12 is knocked out genetically or chemically inhibited. What’s more, when a CDK12 inhibitor is combined with another drug, called a PARP inhibitor, the two drugs double down to deliver a lethal punch to Ewing sarcoma cells.”

Read the full article on for more information.

Posted in Research, Uncategorized.

Leave a Reply

Your email address will not be published. Required fields are marked *